2021-01-11,ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
2021-01-08,Oppenheimer: These 3 Stocks Could Spike Over 80%
2021-01-04,ORIC Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-21,ORIC Pharmaceuticals Announces Initiation of Expansion Cohorts in Phase 1b Study of ORIC-101
2020-12-10,Is ORIC A Good Stock To Buy Now?
2020-12-01,ORIC Pharmaceuticals (ORIC) in Focus: Stock Moves 6.7% Higher
2020-11-17,ORIC Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-11-13,ORIC Pharmaceuticals Announces Pricing of Upsized Public Offering
2020-11-10,ORIC Pharmaceuticals Announces Proposed Public Offering of Common Stock
2020-11-09,ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
2020-11-05,ORIC Pharmaceuticals Reports Third Quarter 2020 Financial and Operational Update
2020-11-04,ORIC Pharmaceuticals (NASDAQ:ORIC) Is In A Good Position To Deliver On Growth Plans
2020-10-19,ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program
2020-10-09,ORIC Pharmaceuticals Announces Presentation of Preclinical Data on Glucocorticoid Receptor Antagonist Overcoming Resistance to an Androgen Receptor Degrader at the 32nd EORTC-NCI-AACR Symposium 2020
2020-09-02,ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
2020-08-06,"What Kind Of Investors Own Most Of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)?"
2020-08-05,ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update
2020-08-05,ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive Worldwide License to Highly Selective Allosteric PRC2 Inhibitors from Mirati Therapeutics
2020-08-03,ORIC Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call
2020-06-22,ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting II
2020-06-09,"ORIC Pharmaceuticals Appoints Lori Kunkel, M.D., to its Board of Directors"
2020-05-27,ORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II
2020-05-26,ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference
2020-05-20,ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results
2020-04-28,ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-04-27,ORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual Meeting
2020-04-23,ORIC Pharmaceuticals Announces Pricing of Initial Public Offering
